| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Monte Rosa Therapeutics, Inc.'s insiders have reduced their positions by a net 13 shares worth roughly $137. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale. Classified under Biotechnology (Health Care sector), GLUE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.69M | - | - | |
| CEO | 585.0K | $13.56M | - | |
| Other | 67.8K | $1.58M | - | |
| COO | 62.4K | $248.2K | - | |
| Other | 60.6K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Dunn Edmund | Principal Accounting Officer | Sell | 139 | $17.96 | $2,496.44 | -0.6% | -4.7% | - | |
| Mar 2, 2026 | Warmuth Markus | President &CEO | Sell10b5-1 | 5,466 | $17.92 | $97,974.22 | -0.9% | +6.3% | - | |
| Mar 2, 2026 | Dunn Edmund | Principal Accounting Officer | Sale+OE | 25,700 | $18.09 | $464,886.15 | -53.1% | +6.3% | - | |
| Feb 23, 2026 | Janku Filip | Chief Medical Officer | Sell | 9,189 | $19.50 | $179,160.69 | -12.2% | -1.6% | - | |
| Jan 7, 2026 | Warmuth Markus | President &CEO | Sell10b5-1 | 5,466 | $23.49 | $128,372.57 | -0.9% | -26.5% | - | |
| Jan 5, 2026 | Dunn Edmund | Principal Accounting Officer | Sell | 1,039 | $15.17 | $15,761.63 | -4.4% | +17.6% | - | |
| Jan 5, 2026 | Townson Sharon | Chief Scientific Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.4% | +17.6% | - | |
| Jan 5, 2026 | Champoux Jennifer | Chief Operating Officer | Sell | 2,629 | $15.17 | $39,881.93 | -4.0% | +17.6% | - | |
| Jan 5, 2026 | Nickson Philip | Chief Business &Legal Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.9% | +17.6% | - | |
| Jan 5, 2026 | Janku Filip | Chief Medical Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.0% | +17.6% | - |